H-ras-transformed NRK-52E renal epithelial cells have altered growth, morphology, and cytoskeletal structure that correlates with renal cell carcinoma in vivo

In Vitro Cellular and Developmental Biology - Animal

Volumn 35, Issue 4, 1999, Pages 205-214

  Best, Carolyn J M ^a   Tanzer, Lee R ^c   Phelps, Patricia C ^a   Merriman, Ronald L ^b,c   Boder, George G ^d   Trump, Benjamin F ^a   Elliget, Kathryn A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d Univ of Maryland School of Medicine ^*

Author keywords

Actin; Cell model; Intermediate filaments; Morphology; Tubulin; Tumorigenicity

Indexed keywords

ACTIN; TUBULIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL KINETICS; CELL TRANSFORMATION; CELL ULTRASTRUCTURE; CYTOSKELETON; EPITHELIUM CELL; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; KIDNEY CARCINOMA; KIDNEY EPITHELIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; RAT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032906873     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-999-0028-2     Document Type: Article

References (57)

1. Andries, M.; Tilemans, D.; Denef, C. Modulation of epidermal growth factor receptor binding and action by N-acetyl-TGFα(34-43) methyl ester. Peptides 15:619-625; 1994.
2. Anzano, M. A.; Rieman, D.; Prichett, W., et al. Growth factor production by human colon carcinoma cell lines. Cancer Res. 49:2898-2904; 1989.
3. Baghdassarian, D.; Toru-Delbauffe, D.; Gavaret, J.-M., et al. Effects of transforming growth factor-β1 on the extracellular matrix and cytoskeleton of cultured astrocytes. Glia 7:193-202; 1993.
4. Bar-Sagi, D.; Feramisco, J. R. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science (Wash., DC) 233:1061-1068; 1986.
5. Basolo, F.; Elliott, J.; Tait, L., et al. Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol. Carcinog. 4:25-35; 1991.
6. Bos, J. B. ras oncogenes in human cancer: a review. Cancer Res. 49:4682-4689; 1989.
7. Burns, J. S.; Blaydes, J. P.; Wright, P. A., et al. Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression. Mol. Carcinog. 6:129-139; 1992.
8. Chou, Y.-H.; Skalli, O.; Goldman, R. D. Intermediate filaments and cytoplasmic networking: new connections and more functions. Curr. Opin. Cell Biol. 9:49-53; 1997.
9. Dartsch, P. C.; Ritter, M.; Häussinger, D., et al. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene. Eur. J. Cell Biol. 63:316-325; 1994.
10. Davis, M. A.; Chang, S. H.; Trump, B. F. Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis. Toxicol. Appl. Pharmacol. 141:93-101; 1996.
11. Davis, M. A.; Smith, M. W.; Chang, S. H., et al. Characterization of a renal epithelial cell model of apoptosis using okadaic acid and the NRK-52E cell line. Toxicol. Pathol. 22:595-605; 1994.
12. DeLarco, J. E.; Todaro, G. J. Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation. J. Cell Physiol. 94:335-342; 1978.
13. Duc-Nguyen, H.; Rosenblum, E. N.; Zeigel, R. F. Persistent infection of a rat kidney cell line with a Rauscher murine leukemia virus. J. Bacteriol. 92:1133-1139; 1966.
14. Durkin, J. P.; Whitfield, J. F. Characterization of the mitogenic signal from an oncogene ras protein. Anticancer Res. 9:1313-1324; 1991.
15. Franch, H. A.; Shay, J. W.; Alpern, R. J., et al. Involvement of the pRB family in TGFβ-dependent epithelial cell hypertrophy. J. Cell. Biol. 129:245-254; 1995.
16. Fukuishi, N.; Gemba, M. Use of cultured renal epithelial cells for the study of cisplatin toxicity. Jpn. J. Pharmacol. 50:247-249; 1989.
17. Garbi, C.; Colletta, G.; Cirafici, A. M., et al. Transforming growth factor-β induces cytoskeleton and extracellular matrix modifications in FRTL-5 thyroid epithelial cells. Eur. J. Cell Biol. 53:281-289; 1990.
18. Geuens, G.; de Brabander, M.; Nuydens, R., et al. The interaction between microtubules and intermediate filaments in cultured cells treated with taxol and nocodazole. Cell Biol. Int. Rep. 7:35-47; 1983.
19. Hartmann, G.; Weidner, K. M.; Schwarz, H., et al. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras. J. Biol. Chem. 269:21936-21939; 1994.
20. Haugen, A.; Ryberg, D.; Hansteen, I., et al. Neoplastic transformation of a human kidney epithelial cell line transfected with v-Ha-ras oncogene. Int. J. Cancer 45:572-577; 1990.
21. Hise, M. K.; Jacobs, S. C.; Papadimitriou, J. C., et al. Transforming growth factor-α expression in human renal cell carcinoma. Urology 47:29-33; 1996.
22. Hordijk, P. L.; ten Klooster, J. P.; van der Kammen, R. A., et al. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science (Wash., DC) 278:1464-1466; 1997.
23. Hotchin, N. A.; Hall, A. The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases. J. Cell Biol. 131:1857-1865; 1995.
24. Houck, K. A.; Michalopoulos, G. K.; Strom, S. C. Introduction of Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-β. Oncogene 4:19-25; 1989.
25. Huber, L. A.; Pasquali, C.; Gagescu, R., et al. Endosomal fractions from viral K-ras-transformed MDCK cells reveal transformation specific changes on two-dimensional gel maps. Electrophoresis 17:1734-1740; 1996.
26. Hugenschmidt, S.; Planas-Bohne, F.; Taylor, D. M. On the toxicity of low doses of tetrasodium-ethylenediamine-tetraacetate (Na-EDTA) in normal rat kidney (NRK) cells in culture. Arch. Toxicol. 67:76-78; 1993.
27. Humes, H. D.; Nakamura, T.; Cieslinski, D. A., et al. Role of proteoglycans and cytoskeleton in the effects of TGF-β1 on renal proximal tubule cells. Kidney Int. 43:575-584; 1993.
28. Hunter, T. Oncoprotein networks. Cell 88:333-346; 1997.
29. Hyman, A. A.; Karsenti, E. Morphogenetic properties of microtubules and mitotic spindle assembly. Cell 84:401-410; 1996.
30. Joneson, T.; White, M. A.; Wigler, M. H., et al. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of Ras. Science 271:810-812; 1996.
31. Kerr, D. I.; Plumb, J. A.; Freshney, R. I., et al. The effect of H-ras oncogene transfection on response on mink lung epithelial cells to growth factors and cytotoxic drugs. Anticancer Res. 11:1349-1352; 1991.
32. Khosravi-Far, R.; Der, C. J. The Ras signal transduction pathway. Cancer Metastasis Rev. 13:67-89; 1994.
33. Konishi, N.; Donovon, P. J.; Ward, J. M. Differential effects of renal carcinogens and tumor promoters on growth promotion and inhibition of gap junctional communication in two rat epithelial cell lines. Carcinogenesis 11:903-908; 1990.
34. Lim, L. C.; Segal, G. H.; Wittwer, C. T. Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin-embedded tissues. Am. J. Clin. Pathol. 104:689-695; 1995.
35. Maniotis, A. J.; Chen, C. S.; Ingber, D. E. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc. Natl. Acad. Sci. USA 94:849-854; 1997.
36. McCormick, F. Activators and effectors of ras p21 proteins. Curr. Opin. Genet. Dev. 4:71-76; 1994.
37. Mulder, K. M.; Morris, S. L. Activation of p21 ras by transforming growth factor β in epithelial cells. J. Biol. Chem. 267:5029-5031; 1992.
38. Ochiai, H.; Ikesue, A.; Kurokawa, M., et al. Enhanced production of rat interleukin-8 by in vitro and in vivo infections with influenza A NWS virus. J. Virol. 67:6811-6814; 1993.
39. Ohgaki, H.; Kleihues, P.; Hard, G. C. Ki-ras mutations in spontaneous and chemically induced renal tumors of the rat. Mol. Carcinog. 4:455-459; 1991.
40. Ohnishi, Y.; Nakamura, H.; Yoshimura, M., et al. Prolonged survival of mice with human gastric cancer treated with an anti-c-erb B-2 monoclonal antibody. Br. J. Cancer 71:969-973; 1995.
41. Phelps, P. C.; Best, C. J. M.; Berezesky, I. K., et al. Studies on the mechanism of sulofenur and LY295501 toxicity: effect on the regulation of cytosolic calcium in relation to cytotoxicity in normal and tumorigenic rat kidney cell lines. Cancer Lett. 97:7-15; 1995.
42. Prendergast, G. C.; Gibbs, J. B. Pathways of Ras function: connections to the actin cytoskeleton. Adv. Cancer Res. 62:19-64; 1993.
43. Qiu, R.-G.; Chen, J.; Kirn, D., et al. An essential role for Rac in Ras transformation. Nature (Lond.) 374:457-459; 1995.
44. Qiu, R.-G.; Chen, J.; McCormick, F., et al. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA 92:11781-11785; 1995.
45. Rak, J.; Mitsuhashi, Y.; Bayko, L., et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55:4575-4580; 1995.
46. Ridley, A.; Comoglio, P. M.; Hall, A. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol. Cell. Biol. 15:1110-1122; 1995.
47. Ridley, A. J.; Paterson, H. F.; Johnston, C. L., et al. The small GTP-binding protein Rac regulates growth factor-induced membrane ruffling. Cell 70:401-410; 1992.
48. Schäfer, R. Suppression of ras oncogene-mediated transformation. Rev. Physiol. Biochem. Pharmacol. 124:30-91; 1994.
49. Va112 oncogene in transformed cell clones. Exp. Cell Res. 168:518-530; 1987.
50. Slebos, H. J. C.; Rodenhuis, S. The ras gene family in human non-small-cell lung cancer. J. Natl. Cancer Inst. 13:23-29; 1992.
51. Spandidos, D. A. Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature (Lond.) 310:469-475; 1984.
52. Stewart, P. M.; Whorwood, C. B. 11-β-Hydroxysteroid dehydrogenase activity and corticosteroid hormone action. Steroids 59:90-95; 1994.
53. Stromskaya, T. P.; Grigorian, I. A.; Ossovskaya, V. S., et al. Cell-specific effects of ras oncogene and protein kinase C agonist TPA on P-glycoprotein function. FEBS Lett. 368:373-376; 1995.
54. Walker, C.; Everitt, J.; Freed, J. J., et al. Altered expression of transforming growth faclor-β in hereditary rat renal carcinoma. Cancer Res. 51:2973-2978; 1991.
55. Watanabe, K.; Kinoshita, S.; Nakagawa, H. Purification and characterization of cytokine-induced neutrophil chemoattractant produced by an epithelioid cell line of normal rat kidney (NRK-52E). Biochem. Biophys. Res. Comm. 161:1093-1099; 1989.
56. Yan, Z.; Winawer, S.; Friedman, K. Two different signal transduction pathways can be activated by transforming growth factor β1 in epithelial cells. J. Biol. Chem. 269:13231-13237; 1994.
57. Yoakum, G. H.; Lechner, J. F.; Gabrielson, E. W., et al. Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene. Science 227:1174-1179; 1985.